Thomas Novelli, MDMA vice president of government relations, believes the same rationale behind the Physician Payment Sunshine provision of the Patient Protection and Affordable Care Act should be applied to the GPO-manufacturer relationships. MDMA’s recommendations include reporting of medical device companies’ payments to GPOs, clear definitions of categories of payment to minimize repetitive reporting and use of a spreadsheet to report data to CMA.
“MDMA strongly believes that providing enhanced transparency within the manufacturer-GPO relationship will benefit all stakeholders,” Mr. Novelli said.
Read MDMA’s letter to CMS about GPO reporting.
Read other coverage about MDMA:
– MDMA Announces Support of Legislation to Strengthen the Research & Development Tax Credit
– MDMA Applauds Bills to Repeal Medical Device Tax
– MDMA Expresses Concern Over ‘Parallel Review’ Process Proposal
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
